Involvement of T-type calcium channels in the mechanism of low dose morphine-induced hyperalgesia in adult male rats
| dc.contributor.author | Abbasloo, Elham | |
| dc.contributor.author | Abdollahi, Farzaneh | |
| dc.contributor.author | Saberi, Arezou | |
| dc.contributor.author | Esmaeili-Mahani, Saeed | |
| dc.contributor.author | Kaeidi, A. | |
| dc.contributor.author | Akhlaghinasab, Fereshteh | |
| dc.contributor.author | Sheibani, Vahid | |
| dc.contributor.author | Thomas, Theresa Currier | |
| dc.contributor.author | Kobeissy, Firas H. | |
| dc.contributor.author | Oryan, Sharbanoo | |
| dc.contributor.department | Biochemistry and Molecular Genetics | |
| dc.contributor.faculty | Faculty of Medicine (FM) | |
| dc.contributor.institution | American University of Beirut | |
| dc.date.accessioned | 2025-01-24T11:38:09Z | |
| dc.date.available | 2025-01-24T11:38:09Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | It has been shown that systemic and local administration of ultra-low dose morphine induced a hyperalgesic response via mu-opioid receptors. However, its exact mechanism(s) has not fully been clarified. It is documented that mu-opioid receptors functionally couple to T-type voltage dependent Ca+2 channels. Here, we investigated the role of T-type calcium channels, amiloride and mibefradil, on the induction of low-dose morphine hyperalgesia in male Wistar rats. The data showed that morphine (0.01 μg i.t. and 1 μg/kg i.p.) could elicit hyperalgesia as assessed by the tail-flick test. Administration of amiloride (5 and 10 μg i.t.) and mibefradil (2.5 and 5 μg i.t.) completely blocked low-dose morphine-induced hyperalgesia in spinal dorsal horn. Amiloride at doses of 1 and 5 mg/kg (i.p.) and mibefradil (9 mg/kg ip) 10 min before morphine (1 μg/kg i.p.) inhibited morphine-induced hyperalgesia. Our results indicate a role for T-type calcium channels in low dose morphine-induced hyperalgesia in rats. © 2021 Elsevier Ltd | |
| dc.identifier.doi | https://doi.org/10.1016/j.npep.2021.102185 | |
| dc.identifier.eid | 2-s2.0-85113197918 | |
| dc.identifier.pmid | 34419803 | |
| dc.identifier.uri | http://hdl.handle.net/10938/28998 | |
| dc.language.iso | en | |
| dc.publisher | Churchill Livingstone | |
| dc.relation.ispartof | Neuropeptides | |
| dc.source | Scopus | |
| dc.subject | Amiloride | |
| dc.subject | Hyperalgesia | |
| dc.subject | Mibefradil | |
| dc.subject | Morphine | |
| dc.subject | Rat | |
| dc.subject | T-type calcium channel | |
| dc.subject | Analgesics, opioid | |
| dc.subject | Animals | |
| dc.subject | Calcium channels, t-type | |
| dc.subject | Dose-response relationship, drug | |
| dc.subject | Injections, intraperitoneal | |
| dc.subject | Male | |
| dc.subject | Pain measurement | |
| dc.subject | Pain threshold | |
| dc.subject | Posterior horn cells | |
| dc.subject | Rats | |
| dc.subject | Rats, wistar | |
| dc.subject | Receptors, opioid, mu | |
| dc.subject | Calcium channel t type | |
| dc.subject | Mu opiate receptor | |
| dc.subject | Narcotic analgesic agent | |
| dc.subject | Adult | |
| dc.subject | Animal experiment | |
| dc.subject | Animal model | |
| dc.subject | Article | |
| dc.subject | Clinical article | |
| dc.subject | Controlled study | |
| dc.subject | Drug delivery system | |
| dc.subject | Low drug dose | |
| dc.subject | Nociception | |
| dc.subject | Nonhuman | |
| dc.subject | Spinal cord dorsal horn | |
| dc.subject | Tail flick test | |
| dc.subject | Wistar rat | |
| dc.subject | Animal | |
| dc.subject | Dose response | |
| dc.subject | Drug effect | |
| dc.subject | Intraperitoneal drug administration | |
| dc.subject | Posterior horn cell | |
| dc.title | Involvement of T-type calcium channels in the mechanism of low dose morphine-induced hyperalgesia in adult male rats | |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1